Forbes contributors publish independent expert analyses and insights. I write about green businesses and how to help startups succeed. This article is more than 10 years old. Think of the last time ...

In the first paper in this series, 1 we presented important considerations in basic statistics and univariate analyses for studies involving outcomes of bone marrow transplantation. Regression or ...

Leaders don’t need more slides—they need more sensemaking. The future of presentations is clarity, story, and presence, not ...

The Statistical & Data Sciences (SDS) Program links faculty and students from across the college interested in learning things from data. At Smith, students learn statistics by doing—class time ...

June 7, 2002 -- When interpreting results of clinical trials, doctors should beware of misleading data presentation, suggests an article in the June 5 issue of The Journal of the American Medical ...

SQZ’s Point-of-Care (POC) Manufacturing Platform Shows Promising Results with Ability to Produce Cell Therapies at Scale in Under 10 Hours WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for indications in virology and ...

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...

CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...